Association between retinal neuronal degeneration and visual function impairment in type 2 diabetic patients without diabetic retinopathy

Abstract

The changes in retinal thickness and visual function in type 2 diabetic patients without clinical evidence of diabetic retinopathy were evaluated. A total of 141 diabetic subjects without retinopathy and 158 healthy subjects were enrolled in this study. Superior macular ganglion cell complex thicknesses were significantly decreased in diabetic cases, and no significant peripapillary retinal nerve fiber layer thickness changes were observed. The contrast sensitivities at all space frequencies were significantly different between diabetic patients and controls. The mean P50 amplitude from pattern electroretinogram results was reduced significantly in the diabetic group. In the diabetic group, average superior ganglion cell complex thicknesses positively correlated with both contrast sensitivities at high spatial frequencies and P50 amplitudes. The results indicated that ganglion cell complex thickness and visual function changes could be observed in diabetic subjects before the onset of any significant diabetic retinopathy. Macular ganglion cell complex reduction occurred much earlier than peripapillary retinal nerve fiber layer thinning in diabetic patients without retinopathy. diabetes mellitus, diabetic retinopathy, retinal nerve fiber layer, retinal ganglion cell, contrast sensitivity, electroretinogram Citation:Zhu TP, Ma J, Li YH, Zhang Z. Association between retinal neuronal degeneration and visual function impairment in type 2 diabetic patients without diabetic retinopathy. Sci China Life Sci, 2015, 58: 550 -555,

The potential role of subclinical ischaemia in the visual dysfunction of patients with type 2 Diabetes Mellitus without diabetic retinopathy

“…These results support previous findings, where loss of contrast sensitivity in type 2 diabetics who do not have diabetic retinopathy was hardly observed [5,14,16]. However, other researchers have found changes affecting CSV in all frequencies in patients with DM2 and no retinopathy [15,17]. It has been suggested that the selective loss of contrast sensitivity for the higher frequencies is a signal of parvocellular dysfunction [18]; this would account for 80% of the retinal ganglion cells (which are parvocellular) [19].…”

“…Thus, the evaluation of CSV in different spatial frequencies is of great importance in these patients. It appears that, in the presence of clinical diabetic retinopathy, a decrease in contrast sensitivity is present [5,14], which may be independent of the visual acuity affectation [5,15].…”

The prevalence of visual impairment and blindness in underserved rural areas: a crucial issue for future

“…It is estimated that implementation of the Vision 2020 will result in the prevention of blindness in 429 million people and 102 billion dollars of economic benefit. 22 Refractive errors were the leading cause of visual impairment in our study, both in the younger and the older age groups. This finding is similar to other studies.…”

Clinical Decision-Making when Treating Diabetic Macular Edema Patients with Dexamethasone Intravitreal Implants

“…Vascular abnormalities and neuronal alterations accompany the pathogenic changes at the earliest stages of diabetic retinopathy, including neural apoptosis, loss of ganglion cells, glial reactivity, and a reduction in the thickness of the inner retinal layers [31]. Capillary obstruction due to leukostasis as well as capillary dropout due to the death of vascular pericytes and endothelial cells lead to tissue ischemia, which triggers the accumulation of a number of proangiogenic factors, including VEGF, erythropoietin, Ang-2, and SDF-1 [24].…”